Adenovirus-mediated gene transfer of fibroblast growth factor-1: Angiogenesis and tumorigenicity in nude mice

Roberto Pili, Joan Chang, Judith Muhlhauser, Ronald Crystal, Maurizio C. Capogrossi, Antonino Passaniti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Gene transfer of angiogenic growth factors with replication-deficient recombinant adenovirus (Ad) vectors may provide a new approach to the treatment of ischemic diseases. To determine if Ad-infected cells could stimulate angiogenesis in vivo and to assess the tumorigenicity of cells infected with these vectors, NIH3T3 fibroblasts infected with Ad vectors coding for human acidic fibroblast growth factor (aFGF-1) were used in angiogenic and tumorigenic assays. Infected cells induced a strong angiogenic response in vivo, while cells infected with control virus did not. Stable 3T3 transfectants expressing the FGF-1 gene were also highly angiogenic and exhibited growth in soft agar, while Ad-infected cells did not. Ad-infected cells grew transiently in nude mice, whereas 3T3 transfectants formed large tumors which grew exponentially. Extrapolation of cell dose-response curves showed that a minimum of 1.5 x 104 infected cells were required for transient tumor cell growth in vivo. Ad-infected cells cultured in vitro for 30 days lost their invasive phenotype and the ability for transient cell growth in nude mice. Thus, phenotypic changes induced by Ad-mediated gene transfer of FGF-I are transient both in vitro and in vivo, suggesting that these Ad vectors do not have tumorigenic potential. Stimulation of angiogenesis by Ad-infected cells may be useful for the evaluation of anti- angiogenic and anti-tumor agents.

Original languageEnglish
Pages (from-to)258-263
Number of pages6
JournalInternational Journal of Cancer
Volume73
Issue number2
DOIs
Publication statusPublished - 29 Oct 1997
Externally publishedYes

Fingerprint

Fibroblast Growth Factor 1
Adenoviridae
Nude Mice
Genes
Growth
Neoplasms
Angiogenesis Inducing Agents
Agar
Cultured Cells
Intercellular Signaling Peptides and Proteins
Fibroblasts

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Adenovirus-mediated gene transfer of fibroblast growth factor-1 : Angiogenesis and tumorigenicity in nude mice. / Pili, Roberto; Chang, Joan; Muhlhauser, Judith; Crystal, Ronald; Capogrossi, Maurizio C.; Passaniti, Antonino.

In: International Journal of Cancer, Vol. 73, No. 2, 29.10.1997, p. 258-263.

Research output: Contribution to journalArticle

Pili, Roberto ; Chang, Joan ; Muhlhauser, Judith ; Crystal, Ronald ; Capogrossi, Maurizio C. ; Passaniti, Antonino. / Adenovirus-mediated gene transfer of fibroblast growth factor-1 : Angiogenesis and tumorigenicity in nude mice. In: International Journal of Cancer. 1997 ; Vol. 73, No. 2. pp. 258-263.
@article{59ad5e1a94ab4b5780dbf3a47bf52036,
title = "Adenovirus-mediated gene transfer of fibroblast growth factor-1: Angiogenesis and tumorigenicity in nude mice",
abstract = "Gene transfer of angiogenic growth factors with replication-deficient recombinant adenovirus (Ad) vectors may provide a new approach to the treatment of ischemic diseases. To determine if Ad-infected cells could stimulate angiogenesis in vivo and to assess the tumorigenicity of cells infected with these vectors, NIH3T3 fibroblasts infected with Ad vectors coding for human acidic fibroblast growth factor (aFGF-1) were used in angiogenic and tumorigenic assays. Infected cells induced a strong angiogenic response in vivo, while cells infected with control virus did not. Stable 3T3 transfectants expressing the FGF-1 gene were also highly angiogenic and exhibited growth in soft agar, while Ad-infected cells did not. Ad-infected cells grew transiently in nude mice, whereas 3T3 transfectants formed large tumors which grew exponentially. Extrapolation of cell dose-response curves showed that a minimum of 1.5 x 104 infected cells were required for transient tumor cell growth in vivo. Ad-infected cells cultured in vitro for 30 days lost their invasive phenotype and the ability for transient cell growth in nude mice. Thus, phenotypic changes induced by Ad-mediated gene transfer of FGF-I are transient both in vitro and in vivo, suggesting that these Ad vectors do not have tumorigenic potential. Stimulation of angiogenesis by Ad-infected cells may be useful for the evaluation of anti- angiogenic and anti-tumor agents.",
author = "Roberto Pili and Joan Chang and Judith Muhlhauser and Ronald Crystal and Capogrossi, {Maurizio C.} and Antonino Passaniti",
year = "1997",
month = "10",
day = "29",
doi = "10.1002/(SICI)1097-0215(19971009)73:2<258::AID-IJC16>3.0.CO;2-B",
language = "English",
volume = "73",
pages = "258--263",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Adenovirus-mediated gene transfer of fibroblast growth factor-1

T2 - Angiogenesis and tumorigenicity in nude mice

AU - Pili, Roberto

AU - Chang, Joan

AU - Muhlhauser, Judith

AU - Crystal, Ronald

AU - Capogrossi, Maurizio C.

AU - Passaniti, Antonino

PY - 1997/10/29

Y1 - 1997/10/29

N2 - Gene transfer of angiogenic growth factors with replication-deficient recombinant adenovirus (Ad) vectors may provide a new approach to the treatment of ischemic diseases. To determine if Ad-infected cells could stimulate angiogenesis in vivo and to assess the tumorigenicity of cells infected with these vectors, NIH3T3 fibroblasts infected with Ad vectors coding for human acidic fibroblast growth factor (aFGF-1) were used in angiogenic and tumorigenic assays. Infected cells induced a strong angiogenic response in vivo, while cells infected with control virus did not. Stable 3T3 transfectants expressing the FGF-1 gene were also highly angiogenic and exhibited growth in soft agar, while Ad-infected cells did not. Ad-infected cells grew transiently in nude mice, whereas 3T3 transfectants formed large tumors which grew exponentially. Extrapolation of cell dose-response curves showed that a minimum of 1.5 x 104 infected cells were required for transient tumor cell growth in vivo. Ad-infected cells cultured in vitro for 30 days lost their invasive phenotype and the ability for transient cell growth in nude mice. Thus, phenotypic changes induced by Ad-mediated gene transfer of FGF-I are transient both in vitro and in vivo, suggesting that these Ad vectors do not have tumorigenic potential. Stimulation of angiogenesis by Ad-infected cells may be useful for the evaluation of anti- angiogenic and anti-tumor agents.

AB - Gene transfer of angiogenic growth factors with replication-deficient recombinant adenovirus (Ad) vectors may provide a new approach to the treatment of ischemic diseases. To determine if Ad-infected cells could stimulate angiogenesis in vivo and to assess the tumorigenicity of cells infected with these vectors, NIH3T3 fibroblasts infected with Ad vectors coding for human acidic fibroblast growth factor (aFGF-1) were used in angiogenic and tumorigenic assays. Infected cells induced a strong angiogenic response in vivo, while cells infected with control virus did not. Stable 3T3 transfectants expressing the FGF-1 gene were also highly angiogenic and exhibited growth in soft agar, while Ad-infected cells did not. Ad-infected cells grew transiently in nude mice, whereas 3T3 transfectants formed large tumors which grew exponentially. Extrapolation of cell dose-response curves showed that a minimum of 1.5 x 104 infected cells were required for transient tumor cell growth in vivo. Ad-infected cells cultured in vitro for 30 days lost their invasive phenotype and the ability for transient cell growth in nude mice. Thus, phenotypic changes induced by Ad-mediated gene transfer of FGF-I are transient both in vitro and in vivo, suggesting that these Ad vectors do not have tumorigenic potential. Stimulation of angiogenesis by Ad-infected cells may be useful for the evaluation of anti- angiogenic and anti-tumor agents.

UR - http://www.scopus.com/inward/record.url?scp=0030768428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030768428&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19971009)73:2<258::AID-IJC16>3.0.CO;2-B

DO - 10.1002/(SICI)1097-0215(19971009)73:2<258::AID-IJC16>3.0.CO;2-B

M3 - Article

C2 - 9335452

AN - SCOPUS:0030768428

VL - 73

SP - 258

EP - 263

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -